retatrutide fda status Weight Loss Results:Trial Data and Trial of next-gen weight-loss drug

CAUTION - Read entire label before consuming

In the SUSTAIN-7 trial , individuals taking 1 mg of semaglutide lost an average of 4.6 kg (10.1 lbs) over 40 weeks compared to 1.9 kg (4.2 lbs) for those on dulaglutide 1.5 mg

Last month, the Massachusetts Center for Health Information and Analysis reported that health care spending climbed 8.6 percent to $78.1 billion in 2023, more than double the states 3.6 percent annual growth benchmark

Tirzepatide activates two receptors (GIP + GLP-1)

This action is bacteriostatic rather than bactericidal, meaning bacterial growth is prevented rather than organisms being directly destroyed